DePuy Synthes, part of J&J, announced the release of its CONFORM SHEET demineralized cancellous bone scaffold that’s designed for implantation during spinal fusion procedures to promote the growth of the patient’s own bone tissue in place of the product.
The material is prepared by the Musculoskeletal Transplant Foundation (MTF) to both provide guidance for tissue growth and to promote undifferentiated stem cells to turn into bone.
From the announcement:
Through a unique demineralization process, bone morphogenic proteins (BMPs) are exposed, providing CONFORM SHEET its osteoinductive properties, while the cancellous structure of the scaffold provides osteoconductive characteristics. CONFORM SHEET is wickable in that it readily absorbs various hydrating fluids including bone marrow aspirate, blood or saline. When combined with bone marrow aspirate, CONFORM SHEET becomes osteogenic.
“CONFORM SHEET has excellent handling characteristics. It is compressible for precise placement, where it can then expand to fill the bone void,” said Khalid Sethi, MD, FACS, Chief of Neurosurgery at United Health Services Wilson Medical Center in Johnson City, NY. “It is packaged in a hydrated state, which eliminates the need for rehydration and there is no implant migration upon irrigation.”
CONFORM SHEET is offered in four sizes, which may be cut to accommodate irregular shaped anatomy. The implant may be used with DePuy Synthes Spine MATRIX™ MIS Pedicle Screw System and EXPEDIUM® Spine System, as well as other systems for spinal fusion.
CONFORM SHEET product brochure…
Press release: DEPUY SYNTHES SPINE LAUNCHES NEW TISSUE IMPLANT FOR SPINE SURGERY, CONFORM SHEET™…
